FDA Approved: ZYKADIA — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved ZYKADIA (ceritinib) as an original new-drug approval for ALK-positive non-small cell lung cancer in patients who progressed on or tolerated crizoti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Zykadia (ceritinib)

Snippet

ORIG AP for ZYKADIA (CERITINIB)